scholarly article | Q13442814 |
P356 | DOI | 10.1016/0022-3956(65)90003-8 |
P698 | PubMed publication ID | 5866611 |
P2093 | author name string | J J Schildkraut | |
E K Gordon | |||
J Durell | |||
P433 | issue | 4 | |
P304 | page(s) | 213-228 | |
P577 | publication date | 1965-12-01 | |
P1433 | published in | Journal of Psychiatric Research | Q6295810 |
P1476 | title | Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine | |
P478 | volume | 3 |
Q47640228 | A brief history of antidepressant drug development: from tricyclics to beyond ketamine |
Q39964156 | A dualistic approach to some biochemical problems in endogenous depressions |
Q41680522 | Antidepressant-Like and Antioxidant Effects of Plinia trunciflora in Mice. |
Q40044181 | Biogenic Amines and Emotion |
Q69517342 | Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects |
Q72368759 | Catechol amines and their metabolites in various states of ‘arousal’ |
Q70506826 | Catecholamine metabolism in affective disorders —IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline |
Q36540629 | Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories |
Q43838094 | Cognitive and biochemical processes in depressed adult outpatients: a test of the circular process model |
Q40038063 | Cyclic AMP in the CSF of Patients with Schizophrenia |
Q41024140 | Decrease in brain NE turnover after chronic DMI treatment; no effect with iprindole |
Q71668291 | Disturbance of tyrosine and tryptophane metabolism in depression |
Q47123548 | Dopamine System Dysregulation in Major Depressive Disorders. |
Q34502872 | Effects of a false neurotransmitter, p-hydroxynorephedrine, on the function of adrenergic neurons in hypertensive patients |
Q48974440 | Effects of tricyclic antidepressants on the uptake and metabolism of intracisternally administered norepinephrine-H3 in rat brain |
Q26828593 | Epigenetic effect of chronic stress on dopamine signaling and depression |
Q43523869 | Hypertension and peptic ulcer |
Q37198752 | Molecular epidemiology of major depressive disorder |
Q37344751 | Neuropsychiatric disorders related to interferon and interleukins treatment |
Q37823751 | Neurotransmitter Mechanisms during Mental Illness Induced by Alterations in Thyroid Function |
Q53957522 | Noradrenergic activity during the transition from depression to mania. |
Q95643364 | Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators |
Q61456993 | Plasma renin activity in primary and secondary depression |
Q48431061 | Potentiating effect of lithium chloride on aggressive behaviour induced in mice by nialamide plus L-DOPA and by clonidine |
Q70506833 | Psychobiological and pharmacological studies of manic-depressive illness |
Q39973602 | Recent Contributions to Psychoendocrinology Part II |
Q33945106 | Research and treatment approaches to depression |
Q48465397 | Role of biogenic amines in certain pathological conditions |
Q39514501 | Schizophrenia: instability in norepinephrine, serotonin, and gamma-aminobutyric acid systems. |
Q72026328 | Schizophrenic Physiopathology |
Q51230807 | The effects of lithium ion on H3 -norepinephrine metabolism in brain |
Q51219079 | The effects of psychoactive drugs on norepinephrine-3H metabolism in brain |
Q69544110 | The tyrosine-tryptophan-diagram in a longtime study with depressed patients |
Q39992599 | Theories of Biological Etiology of Affective Disorders |
Q70506830 | Thyroid-imipramine clinical and chemical interaction: Evidence for a receptor deficit in depression |
Q72453816 | Thyrotropin releasing hormone: Neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines |
Q72369366 | Tricyclic Antidepressants: Evidence for an Intraneuronal Site of Action |
Q34048096 | Tryptophan, depression and steroidal contraception |
Q69469954 | Urinary Catecholamine Metabolites during Behavioral Changes in a Patient with Manic-Depressive Cycles |
Search more.